Shinko Asset Management Company’s BioMarin Pharmaceuticals BMRN Stock Holding History

Shinko Asset Management Company’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$42K	Hold	450	–	–	﹤0.01%	550
2016 Q2	$35K	Hold	450	–	–	﹤0.01%	576
2016 Q1	$37K	Hold	450	–	–	﹤0.01%	573
2015 Q4	$47K	Hold	450	–	–	﹤0.01%	539
2015 Q3	$47K	Sell	450 -42	-9%	-$5.61K	﹤0.01%	529
2015 Q2	$67K	Hold	492	–	–	﹤0.01%	402
2015 Q1	$61K	Hold	492	–	–	﹤0.01%	377
2014 Q4	$44K	Sell	492 -100	-17%	-$8.32K	﹤0.01%	483
2014 Q3	$43K	Hold	592	–	–	﹤0.01%	515
2014 Q2	$37K	Hold	592	–	–	﹤0.01%	583
2014 Q1	$40K	Sell	592 -108	-15%	-$7.96K	﹤0.01%	549
2013 Q4	$49K	Hold	700	–	–	﹤0.01%	492
2013 Q3	$51K	Buy	700 +100	+17%	+$6.65K	﹤0.01%	472
2013 Q2	$33K	Buy	+600	New	+$37.4K	﹤0.01%	599

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Shinko Asset Management Company's BMRN Position: Q3 2016 in Review

Shinko Asset Management Company held its BioMarin Pharmaceuticals (BMRN) position steady in Q3 2016 at 450 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #550.

Shinko Asset Management Company first reported a position in BMRN in Q2 2013 and has held it in 14 quarters since. The position peaked at $67K in Q2 2015. 423 funds tracked by Wall St. Rank hold BMRN as of Q3 2016.

Shinko Asset Management Company held 450 shares of BioMarin Pharmaceuticals worth $42K as of Q3 2016.
Shinko Asset Management Company left its BioMarin Pharmaceuticals share count unchanged in Q3 2016.
BioMarin Pharmaceuticals made up ﹤0.01% of Shinko Asset Management Company's portfolio in Q3 2016, its #550 holding.
Shinko Asset Management Company first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
Shinko Asset Management Company's BioMarin Pharmaceuticals position peaked at $67K in Q2 2015.
423 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.